Innovations in Precision Medicine, Cell Therapies, Vaccines, Gene Therapy, 3D Bioprinting and Alzheimer’s Treatment, 2019 Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--May 13, 2019--
The “Innovations in Precision Medicine, Cell Therapies, Vaccines, Gene Therapy, 3D Bioprinting and Alzheimer’s Treatment” report has been added to ResearchAndMarkets.com’s offering.
The Life Science, Health & Wellness TechVision Opportunity Engine (TOE) comprises analytical insights across global innovations in cell therapy, biomanufacturing precision medicine, PCR, solid dose formulations, diagnostics, 3D bioprinting, vaccines, and biologics platforms.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
- AUM Biosciences
- Astellas Institute for Regenerative Medicine
- BioNTech AG
- Cellink AB
- Cytovant Sciences
- DNAe Group Holdings Ltd.
- DxNV LLC
- EIP Pharma
- Emergex Vaccines Holding Ltd.
- Enesi Pharma Limited
- Fortuna Fix
- Fujifilm Diosynth Biotechnologies
- GNA Biosolutions GmbH
- GT Biopharma
- Georgetown University Medical Center
- IBM Research Labs
- National Eye Institute, NIH
- National Institute of Health
- NuProbe Inc.
- Orchard Therapeutics Limited
- PMV Pharmaceuticals
- SCYNEXIS Inc.
- Scripps Research Institute
For more information about this report visit https://www.researchandmarkets.com/r/fitggo
View source version on businesswire.com:https://www.businesswire.com/news/home/20190513005590/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Genomics,Biomaterials ,Vaccines,Alzheimer’s Disease Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 05/13/2019 11:24 AM/DISC: 05/13/2019 11:24 AM